Natraj Proteins Gains 12.57%: 3 Key Factors Driving the Week’s Volatility

16 March 2026: Downgrade to Strong Sell Amid Bearish Technicals

On Monday, Natraj Proteins opened the week under pressure, closing at Rs.31.00, down 2.12% from the previous close of Rs.31.67. This decline coincided with MarketsMOJO’s downgrade of the stock’s rating from Sell to Strong Sell, citing deteriorating technical indicators and weak fundamentals. The technical outlook had shifted to outright bearish, with monthly MACD and Bollinger Bands signalling increased selling pressure. Despite a recent positive quarterly performance, the stock’s long-term sales growth remained negative at a CAGR of -5.06%, and profitability ratios such as ROE and ROCE were modest at 6.97% and 1% respectively. The downgrade reflected concerns over sustained downward momentum and valuation risks, with the stock trading near its 52-week low of Rs.28.00.

17 March 2026: Continued Pressure Amid Downgrade Impact

The bearish sentiment persisted on Tuesday, with the stock falling sharply by 4.68% to close at Rs.29.55. This decline occurred despite the Sensex gaining 0.79%, highlighting the stock’s underperformance relative to the broader market. Trading volumes surged to 11,001 shares, indicating increased selling activity. The downgrade’s impact was evident as investors reacted to the negative technical signals and cautious outlook. The stock’s valuation remained low, but concerns about operational challenges and micro-cap volatility weighed heavily on sentiment.

18 March 2026: Valuation Upgraded to Very Attractive Amid Market Challenges

Wednesday marked a significant turnaround as Natraj Proteins surged 20.00% to close at Rs.35.46, outperforming the Sensex’s 1.15% gain. This rally followed an upgrade in the company’s valuation grade from Attractive to Very Attractive, driven by compelling price multiples. The stock’s P/E ratio stood at 8.58, substantially below sector peers such as AVT Natural Products (15.68) and Gokul Refoils (20.78). The price-to-book ratio compressed to 0.38, signalling undervaluation relative to book equity. Enterprise value multiples also favoured the stock, with EV/EBITDA at 8.29 and EV/CE at 0.63. Despite these valuation positives, operational returns remained modest, with ROCE at 1.03% and ROE at 4.40%. The valuation upgrade suggested a potential value opportunity amid ongoing market headwinds and sector volatility.

19 March 2026: Upgrade to Sell on Technical and Valuation Improvements

On Thursday, the stock extended its gains, closing at Rs.38.35, up 8.15% on heavy volume of 46,772 shares. This price surge followed MarketsMOJO’s upgrade of the rating from Strong Sell to Sell, reflecting a cautious but positive shift in technical indicators and valuation metrics. Weekly MACD turned mildly bullish, and Bollinger Bands suggested increased price stability. Valuation multiples remained attractive, with the P/E ratio improving to 10.3 and price-to-book at 0.45. Enterprise value multiples also supported the upgrade, with EV/EBIT at 9.76 and EV/EBITDA at 8.88. Despite these improvements, long-term fundamentals remained mixed, with a negative five-year sales CAGR and modest profitability. The upgrade signalled a tentative stabilisation in the stock’s outlook amid ongoing challenges.

20 March 2026: Profit Taking and Week Close

Friday saw a correction as the stock retreated 7.04% to close at Rs.35.65, on lower volume of 5,903 shares. This pullback occurred despite the Sensex gaining 0.51%, reflecting profit-taking after the prior day’s strong rally. The week ended with a net gain of 12.57%, significantly outperforming the Sensex’s 0.28% decline. The stock’s volatility throughout the week underscored the market’s mixed sentiment, balancing technical upgrades and valuation appeal against persistent fundamental concerns.

Key Takeaways

Positive Signals: The week’s strong price rebound was driven by improved technical indicators and a more attractive valuation profile. The upgrade from Strong Sell to Sell reflected stabilising momentum, with weekly MACD turning mildly bullish and Bollinger Bands suggesting reduced volatility. Valuation multiples such as P/E (around 10.3) and price-to-book (0.45) remain well below sector averages, highlighting potential value for investors willing to accept micro-cap risks. The company’s recent quarterly results showed operational improvement, with the highest quarterly PBDIT of Rs.3.54 crores and an operating profit to net sales ratio of 12.3%.

Cautionary Signals: Despite short-term gains, Natraj Proteins’ long-term fundamentals remain weak. The five-year negative sales CAGR of -5.06% and modest profitability ratios (ROE 6.97%, ROCE 1.03%) underscore persistent challenges. The stock’s micro-cap status and predominantly non-institutional shareholder base contribute to volatility and liquidity risks. The sharp intraday price swings and the 7.04% drop on the final trading day reflect ongoing uncertainty. Additionally, the stock’s underperformance relative to the Sensex over one, three, five, and ten-year horizons highlights structural weaknesses that temper enthusiasm.

Conclusion

Natraj Proteins Ltd’s week was marked by significant volatility, driven by a series of rating changes and valuation reassessments. The stock’s 12.57% weekly gain outpaced the Sensex’s slight decline, reflecting renewed investor interest amid stabilising technical indicators and compelling valuation multiples. However, the company’s weak long-term financial trends and micro-cap risks remain salient concerns. The cautious upgrade from Strong Sell to Sell signals a tentative improvement but underscores the need for prudence. Investors should weigh the attractive valuation against persistent operational challenges and market volatility before considering exposure to this edible oil sector micro-cap.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today